Oxford Transplant Centre, Oxford, UK.
Curr Opin Organ Transplant. 2013 Feb;18(1):83-8. doi: 10.1097/MOT.0b013e32835c29ef.
Pancreas transplantation is still hampered by a high incidence of early graft loss, and organ quality concerns result in high nonrecovery/discard rates. Demographic donor characteristics, surgical retrieval strategy, preservation fluid and ischemia time are crucial factors in the process of organ selection and are discussed in this review.
The donor shortage is driving an increasing utilization of nonideal organs which would previously have been identified as unsuitable. Recent literature suggests that organs from extended criteria donors - older (>45 years), BMI >30 kg/m(2), and donation after cardiac death (DCD) - can achieve the same graft and patient survival as those from standard criteria donors, with the proviso that the accumulation of risk factors and long ischemic times should be avoided. Visual assessment of the pancreas is advisable before declining/accepting a pancreas. University of Wisconsin represents the gold standard solution; however, histidine-tryptophan-ketoglutarate and Celsior result in equal outcomes if cold ischemia time (CIT) is less than 12 h. Currently in pancreas transplantation, there is no proven effective ischemia/reperfusion injury prophylaxis than trying to keep CIT as short as possible.
Demographic risk factors, inspection of the pancreas by an experienced surgeon and predicted CIT are crucial factors in deciding whether to accept a pancreas for transplantation. However, there is a need for an improved evidence base to determine where to set the 'cut-off' for unsuitable pancreatic grafts.
胰腺移植仍然受到早期移植物失功发生率高的困扰,而且器官质量问题导致了高未恢复/废弃率。本文讨论了选择供体器官过程中的关键因素,包括供体的人口统计学特征、外科获取策略、保存液和缺血时间。
供体短缺促使人们越来越多地使用以前被认为不合适的非理想器官。最近的文献表明,来自扩展标准供体(年龄>45 岁、BMI>30kg/m² 和心脏死亡后捐献(DCD))的器官可以达到与标准供体相同的移植物和患者存活率,但应避免危险因素的积累和较长的缺血时间。在拒绝/接受胰腺之前,对胰腺进行视觉评估是明智的。威斯康星大学方案是金标准解决方案;然而,如果冷缺血时间(CIT)小于 12 小时,组氨酸-色氨酸-酮戊二酸和 Celsior 可产生相同的结果。目前,在胰腺移植中,没有比尽量缩短 CIT 更有效的缺血/再灌注损伤预防方法。
人口统计学危险因素、经验丰富的外科医生对胰腺的检查和预测的 CIT 是决定是否接受胰腺进行移植的关键因素。然而,需要有一个更好的证据基础来确定不适合胰腺移植物的“截止点”。